Cyxone files new patent applications following additional innovation achievements
Cyxone (publ), a Swedish biotech in autoimmune diseases, announces today that the company has filed four patent applications for protection of new innovation achievements. The applications have been filed to relevant patent authorities.With these new patents, Cyxone will have wider protection for the company’s therapeutic scope as well as for the manufacturing and formulation processes. Cyxone is looking into opportunities to file more patent applications in the near future. Cyxone is unable to disclose more information regarding the filed patents at this point. The patents filed